Metabolic vulnerabilities associated to G12C inhibitor resistance
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210023
- Recipient
-
University Of Illinois UEI W8XEAJDKMXH3 Part of University Of Illinois
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $159,892
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Chicago, IL 60612, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will further those goals by investigating metabolic factors that contribute to resistance against a class of drugs used to treat certain cancers. Insights gained from the research could help overcome treatment barriers and improve health outcomes for service members and civilians alike.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $159,892 |
Quick answers
Who received award W81XWH2210023?
W81XWH2210023 was awarded to University Of Illinois by Defense Health Agency (Department of Defense) on January 1, 2022.
How much is award W81XWH2210023 worth?
$159,892 has been obligated on W81XWH2210023.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award